Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cognitive motor interference during walking in multiple sclerosis using an alternate letter alphabet task.
Calcium intervention ameliorates experimental model of multiple sclerosis.
Reduced spontaneous sympathetic nerve activity in multiple sclerosis patients.
Vitamin D as a protective factor in multiple sclerosis.
The Falls Efficacy Scale International: A Cross-Sectional Validation in People with Multiple Sclerosis.
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.
[Multiple sclerosis: new drugs and their molecular targets].
The best clinical paper on multiple sclerosis in 2012.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
T-bet Expression by Foxp3(+) T Regulatory Cells is Not Essential for Their Suppressive Function in CNS Autoimmune Disease or Colitis.
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?
Excitability decreasing central motor plasticity is retained in multiple sclerosis patients.
Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'
Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.
Vitamin D in autoimmune liver disease.
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
[Natalizumab as induction therapy in multiple sclerosis.]
Identification of Bax-Interacting Proteins in Normal Oligodendrocyte Progenitors during Glutamate Excitotoxicity and Perinatal Hypoxia-Ischemia.
Trigeminal neuralgia: A new therapy?
The role of Ets2 transcription factor in the induction of microRNA-155 by LPS, and its targeting by IL-10.
Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.

Pages